Marc Arbyn

Summary

Affiliation: Scientific Institute of Public Health
Country: Belgium

Publications

  1. ncbi Belgian Parliament calls for organised cervical cancer screening and HPV research throughout Europe
    Marc Arbyn
    European Network of Cervical Cancer Screening, Scientific Institute of Public Health, Brussels, Belgium
    Lancet Oncol 3:74. 2002
  2. ncbi Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsmanstreet 14, Brussels, Belgium
    Vaccine 24:S3/78-89. 2006
  3. ncbi European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium, and European Cancer Network, IARC, Lyon, France
    Cytopathology 18:133-9. 2007
  4. ncbi The burden of cervical cancer in south-east Europe at the beginning of the 21st century
    Marc Arbyn
    Scientific Institute of Public Health, Unit of Cancer Epidemiology, Brussels, Belgium
    Coll Antropol 31:7-10. 2007
  5. doi Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
    Marc Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    J Cell Mol Med 13:648-59. 2009
  6. ncbi Burden of cervical cancer in Europe: estimates for 2004
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    Ann Oncol 18:1708-15. 2007
  7. ncbi Trend of cervical cancer mortality in Belgium (1954-1994): tentative solution for the certification problem of unspecified uterine cancer
    Marc Arbyn
    Department of Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Cancer 102:649-54. 2002
  8. ncbi Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears
    Marc Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    Cancer 99:9-16. 2003
  9. ncbi Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
    Marc Arbyn
    European Network for Cervical Cancer Screening and Unit for Evaluation of Cancer Screening Programmes, Scientific Institute of Public Health, Brussels, Belgium
    J Natl Cancer Inst 96:280-93. 2004
  10. ncbi Cervical cytology biobanking in Europe
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Biol Markers 25:117-25. 2010

Detail Information

Publications55

  1. ncbi Belgian Parliament calls for organised cervical cancer screening and HPV research throughout Europe
    Marc Arbyn
    European Network of Cervical Cancer Screening, Scientific Institute of Public Health, Brussels, Belgium
    Lancet Oncol 3:74. 2002
  2. ncbi Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsmanstreet 14, Brussels, Belgium
    Vaccine 24:S3/78-89. 2006
    ..More than ever, clinicians need regularly updated reviews given the continuously increasing amount of new information regarding innovative cervical cancer prevention methods...
  3. ncbi European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium, and European Cancer Network, IARC, Lyon, France
    Cytopathology 18:133-9. 2007
    ..Subsequently, the slide or vial and the completed request form are sent to the laboratory for cytological interpretation...
  4. ncbi The burden of cervical cancer in south-east Europe at the beginning of the 21st century
    Marc Arbyn
    Scientific Institute of Public Health, Unit of Cancer Epidemiology, Brussels, Belgium
    Coll Antropol 31:7-10. 2007
    ..Thus, appropriate cervical cancer prevention programmes should be set up without delay in this part of Europe...
  5. doi Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate
    Marc Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    J Cell Mol Med 13:648-59. 2009
    ..Research is needed to identify more specific methods to triage women with low-grade squamous cervical lesions...
  6. ncbi Burden of cervical cancer in Europe: estimates for 2004
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    Ann Oncol 18:1708-15. 2007
    ..The European Commission should maintain cervical cancer control in future action plans and increase support to the most affected member states...
  7. ncbi Trend of cervical cancer mortality in Belgium (1954-1994): tentative solution for the certification problem of unspecified uterine cancer
    Marc Arbyn
    Department of Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Cancer 102:649-54. 2002
    ..The tendency of increasing mortality in women born after 1935 required particular attention. Nevertheless, the slope of the corrected recent cohort effect remained limited in Belgium, probably as a consequence of screening...
  8. ncbi Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears
    Marc Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    Cancer 99:9-16. 2003
    ..In a previous study, we pooled data on the diagnostic quality of rapid reviewing (RR) of cervical smears initially reported as normal or unsatisfactory. We now focus on rapid prescreening (RPS) of unreported smears...
  9. ncbi Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia
    Marc Arbyn
    European Network for Cervical Cancer Screening and Unit for Evaluation of Cancer Screening Programmes, Scientific Institute of Public Health, Brussels, Belgium
    J Natl Cancer Inst 96:280-93. 2004
    ..We performed a meta-analysis to assess the accuracy of human papillomavirus (HPV) DNA testing as an alternative to repeat cytology in women who had equivocal results on a previous Pap smear...
  10. ncbi Cervical cytology biobanking in Europe
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Biol Markers 25:117-25. 2010
    ..To understand the limitations of CCB, more studies are needed on the quality of samples in relation to sample type, storage procedures, and duration of storage...
  11. doi Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Cancer 128:1899-907. 2011
    ..Rising trends of cervical cancer in the most affected EU member states reveal a worrying pattern that warrants urgent preventive actions...
  12. doi Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium Electronic address
    Lancet Oncol 15:172-83. 2014
    ..However, the clinical accuracy of HPV testing on self-samples is not well-known. We assessed whether HPV testing on self-collected samples is equivalent to HPV testing on samples collected by clinicians...
  13. ncbi HPV testing and vaccination in Europe
    Simon C Leeson
    1Department of Obstetrics and Gynaecology, Betsi Cadwaladr University Health Board, Bangor, Gwynedd, UK 2Department of Gynecology, National Screening Center, Tbilisi, Georgia 3Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium 4Laboratoire Cerba, Paris, France 5Department of Gynecology and Obstetrics, University of Bari, Bari, Italy 6Hôpital Tenon, Service de gynécologie obstétrique et médecine de la reproduction, Paris, France 7Department of Obstetrics and Gynecology, Helsinki University Hospital, Finland 8The Beacon Hospital, Sandyford, Dublin, Ireland 9Department of Obstetrics and Gynaecology, University Hospital of North Staffordshire, Stoke on Trent, UK 10D 18437 Stralsund, Grünthal, Germany and 11Department of Obstetrics and Gynaecology, Klinikum Wolfsburg, Wolfsburg, Germany
    J Low Genit Tract Dis 18:61-9. 2014
    ..HPV vaccination will require many years to evaluate any beneficial effects on cervical cancer incidence and mortality. ..
  14. doi Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Cochrane Database Syst Rev 3:CD008054. 2013
    ..This review evaluates two ways to triage women with ASCUS or LSIL: repeating the cytological test, and DNA testing for high-risk types of the human papillomavirus (hrHPV) - the main causal factor of cervical cancer...
  15. doi Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Vaccine 30:F88-99. 2012
    ..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
  16. doi The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Cancer 132:101-8. 2013
    ..35; 95% CI = 1.11-1.66). Results were similar for detection of CIN2 or worse. In both triage of ASC-US and LSIL, APTIMA is as sensitive but more specific than HC2 for detecting cervical precancer...
  17. ncbi Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types
    Freija Verdoodt
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Cancer Cytopathol 121:675-87. 2013
    ..However, no consensus has been reached on the optimal management of low-grade squamous intraepithelial lesions (LSIL)...
  18. doi p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis
    Jolien Roelens
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Cancer Cytopathol 120:294-307. 2012
    ..74 [95% CI, 1.99-3.76]). The published literature indicated the improved accuracy of p16(INK4a) compared with HC2 testing in the triage of women with ASC-US. In LSIL triage, p16(INK4a) was more specific but less sensitive...
  19. ncbi A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
    Philip Davies
    European Cervical Cancer Association, 68 cours Albert Thomas, Lyon, France
    Int J Cancer 118:791-6. 2006
    ..Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test...
  20. pmc EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Int J Cancer 131:1969-82. 2012
    ....
  21. doi Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India
    Marc Arbyn
    Scientific Institute of Public Health, Unit of Cancer Epidemiology, Brussels, Belgium
    Int J Cancer 123:153-60. 2008
    ..Gold standard verification error could also explain the surprisingly low sensitivity of HC2, which contrasts with findings from other studies...
  22. doi Liquid compared with conventional cervical cytology: a systematic review and meta-analysis
    Marc Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    Obstet Gynecol 111:167-77. 2008
    ..To compare test performance characteristics of conventional Pap tests and liquid-based cervical cytology samples...
  23. doi Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsmanstreet 14, BE 1050 Brussels, Belgium
    Cancer Epidemiol Biomarkers Prev 18:321-30. 2009
    ....
  24. doi Cervical cytology biobanks as a resource for molecular epidemiology
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Methods Mol Biol 675:279-98. 2011
    ..To understand the limitations of CCB, more studies are needed on quality of samples in relation to sample type, storage procedures, and duration of storage...
  25. doi Inter-laboratory variability in the presence of human papillomavirus in normal and abnormal cervical cytology samples
    Christine Weyn
    Unit of Microbiology, Faculty of Pharmacy, Universite Libre de Bruxelles, Brussels, Belgium
    Cancer Epidemiol 37:457-61. 2013
    ..High-risk human papillomavirus (HPV) infection and persistency are necessary to the development of precancerous and cancerous lesions leaving the possibility to detect in time cells progressing in at risk behaviour...
  26. doi Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000)
    Marc Arbyn
    Belgian Cancer Center Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsman Street 14, Brussels, Belgium
    Prev Med 48:438-43. 2009
    ..Cervical cancer screening by surveys overestimate coverage because of selection and reporting biases...
  27. doi The challenges of organising cervical screening programmes in the 15 old member states of the European Union
    Marc Arbyn
    Unit of Cancer Epidemiology and Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium
    Eur J Cancer 45:2671-8. 2009
    ....
  28. doi Cytological screening for cervical cancer in the province of Limburg, Belgium
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Eur J Cancer Prev 20:18-24. 2011
    ..Obligatory registration, use of a uniform terminology and linkage with population and follow-up data are needed to give a cytology registry its full role in an organized screening programme...
  29. ncbi Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania
    Marc Arbyn
    Unit of Cancer Epidemiology Scientific Institute of Public Health, Brussels, Belgium
    Tumori 96:517-23. 2010
    ..The burden of cervical cancer varies considerably in the European Union. In this paper, we describe trends in incidence of and mortality from this cancer in the five most affected member states...
  30. ncbi Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    Gynecol Oncol 99:S7-11. 2005
    ..By triage, those women can be identified who need referral for diagnostic exploration with colposcopy and/or biopsy...
  31. pmc Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
    M Arbyn
    Scientific Institute of Public Health, Brussels, Belgium
    BMJ 337:a1284. 2008
    ..To assess the relative risk of perinatal mortality, severe preterm delivery, and low birth weight associated with previous treatment for precursors of cervical cancer...
  32. pmc Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (belgium, 2002-2006)
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    PLoS ONE 9:e92615. 2014
    ..To assess the coverage for cervical cancer screening as well as the use of cervical cytology, colposcopy and other diagnostic and therapeutic interventions on the uterine cervix in Belgium, using individual health insurance data...
  33. ncbi Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    J Clin Virol 38:189-97. 2007
    ..The purpose of the appendix on vaccination is to present current knowledge. Developing guidelines for future use of HPV vaccines in Europe, is the object of a new grant offered by the European Commission...
  34. pmc How to evaluate emerging technologies in cervical cancer screening?
    Marc Arbyn
    Unit of Cancer Epidemiology Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium
    Int J Cancer 125:2489-96. 2009
    ..The 5-phases framework should guide researchers and test developers in planning assessment of new biomarkers and protect clinicians and stakeholders against premature claims for insufficiently evaluated products...
  35. pmc European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document
    M Arbyn
    Unit of Cancer Epidemiology Belgian Cancer Center, Scientific Institute of Public Health, Brussels, Belgium
    Ann Oncol 21:448-58. 2010
    ....
  36. doi Transmission of carcinogenic human papillomavirus types from mother to child: a meta-analysis of published studies
    Mireille Merckx
    Department of Gynaecology, University Hospital, Scientific Institute for Public Health, Brussels, Belgium
    Eur J Cancer Prev 22:277-85. 2013
    ..More research is required to gain an insight into the precise mode of transmission and the clinical effects of infection on the child...
  37. pmc Impact of genetic notification on smoking cessation: systematic review and pooled-analysis
    Sylviane de Viron
    Operational Direction Public Health and Surveillance, Scientific Institute of Public Health, Brussels, Belgium
    PLoS ONE 7:e40230. 2012
    ..Secondary objectives were to assess the impact of genetic notification on intention-to-quit smoking and on emotional outcomes as well as the understanding and the recall of this notification...
  38. doi Trends of cervical cancer mortality in the member states of the European Union
    Marc Arbyn
    Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium
    Eur J Cancer 45:2640-8. 2009
    ..In the current paper, we analyse cervical cancer mortality trends in the 27 member states since 1970 and, subsequently, try to explain how screening and other factors have driven changes...
  39. ncbi Cervical cancer screening in Belgium
    M Arbyn
    Scientific Institute of Public Health, J Wytsmanstreet 14, B 1050, Belgium
    Eur J Cancer 36:2191-7. 2000
    ..The coverage is lower in the Walloon and the Capital Region. Rationalisation of the policy regarding cancer screening involving all concerned authorities of the country is necessary...
  40. ncbi The future role for colposcopy in Europe
    Simon C Leeson
    1Department of Obstetrics and Gynaecology, Betsi Cadwaladr University Health Board, Bangor, Gwynedd, UK 2Department of Gynecology, National Screening Center, Tbilisi, Georgia 3Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium 4Laboratoire Cerba, Paris, France 5Department of Gynecology and Obstetrics, University of Bari, Bari, Italy 6Hôpital Tenon, Service de gynécologie obstétrique et médecine de la reproduction, Paris, France 7Department of Obstetrics and Gynecology, Helsinki University Hospital, Finland 8The Beacon Hospital, Sandyford, Dublin, Ireland 9Department of Obstetrics and Gynaecology, University Hospital of North Staffordshire, Stoke on Trent, UK 10D 18437 Stralsund, Grünthal, Germany and 11Department of Obstetrics and Gynaecology, Klinikum Wolfsburg, Wolfsburg, Germany
    J Low Genit Tract Dis 18:70-8. 2014
    ..The development of quality assurance across Europe accompanying these program changes is discussed. ..
  41. doi International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention
    Marc Arbyn
    Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
    Cancer Lett 278:1-2. 2009
    ....
  42. pmc Monitoring of human papillomavirus vaccination
    J Dillner
    WHO HPV LabNet Global Reference Laboratory at Department of Clinical Microbiology, University Hospital, Malmo
    Clin Exp Immunol 163:17-25. 2011
    ..Internationally standardized monitoring and evaluation of prophylactic HPV vaccination programmes will be essential for arriving at the most cost-effective strategies for cancer control...
  43. ncbi Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies
    George Koliopoulos
    Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK
    Gynecol Oncol 104:232-46. 2007
    ..This is a meta-analysis of studies comparing HPV testing to cytology with regard to their accuracy in the detection of underlying high grade cervical intraepithelial neoplasia in primary cervical cancer screening...
  44. ncbi Parliament calls for organised cervical cancer screening and HPV research
    Marc Arbyn
    Eur J Obstet Gynecol Reprod Biol 101:101-2. 2002
  45. ncbi European Union support for a Turkish reproductive health project to assess alternative cervical cancer screening methods in Sanliurfa (rural south-east Turkey)
    Marc Arbyn
    Eur J Cancer Prev 15:552-3. 2006
  46. ncbi Human papillomavirus testing with conventional Pap smear screening in three inner London community clinics
    Amanda Herbert
    Histopathology Department, St Thomas Hospital, London, UK
    J Fam Plann Reprod Health Care 33:171-6. 2007
    ..Outcome at colposcopy was compared with the records of 1871 women aged 20-49 years attending colposcopy during the same period of time (routine colposcopies)...
  47. pmc Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis
    Lynne Gaffikin
    Cervical Cancer Prevention Program, JHPIEGO, Baltimore, USA
    BMC Med Res Methodol 7:36. 2007
    ..The data were originally collected at peri-urban health clinics in Zimbabwe...
  48. ncbi Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study
    Shaira Sahebali
    Department of Pathology, University of Antwerp, Groenenborgerlaan 171, BE 2020 Antwerp, Belgium
    Int J Cancer 118:1254-60. 2006
    ..However, clear methodological standards are needed for optimal performance of immunocytochemistry in a clinical setting...
  49. ncbi The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature
    Evangelos Paraskevaidis
    Department of Obstetrics and Gynecology, University Hospital of Ioannina, Greece
    Cancer Treat Rev 30:205-11. 2004
    ..There is an emerging interest concerning the role HPV DNA testing in the follow-up period after conservative treatment for cervical intraepithelial neoplasia...
  50. doi Improving the quality of communication in organised cervical cancer screening programmes
    Livia Giordano
    CPO Piemonte, Torino, Italy
    Patient Educ Couns 72:130-6. 2008
    ..To provide health professionals involved in cervical cancer screening with an insight into the complex issues relating to communication about screening and to provide a framework for a more effective communication strategy...
  51. ncbi Re: Have we resolved how to triage equivocal cervical cytology?
    Marc Arbyn
    J Natl Cancer Inst 96:1401-2; author reply 1402. 2004
  52. ncbi Report on the 2007 International Workshop on Human Papillomaviruses and Consensus Recommendations for Cervical Cancer Prevention
    Magdalena Grce
    Division of Molecular Medicine, Ruder Boskovic Institute, Department of Molecular Medicine, Zagreb, Croatia
    Cent Eur J Public Health 16:38-40. 2008
    ....
  53. doi Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective study
    Silke Schockaert
    Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Catholic University Leuven, Leuven, Belgium
    Am J Obstet Gynecol 199:113.e1-5. 2008
    ..Hysterectomy with concomitant cervical intraepithelial neoplasia (CIN), is often considered a definitive treatment for CIN, but development of subsequent vaginal intraepithelial neoplasia (VAIN) is known to range from 0.9% to 6.8%...
  54. pmc European Commission's proposal for a council recommendation on cancer screening
    Marc Arbyn
    BMJ 327:289-90. 2003
  55. ncbi Effects of quadrivalent human papillomavirus vaccination
    Marc Arbyn
    Lancet 370:1031-2; author reply 1032-3. 2007